RESUMEN
BACKGROUND AND OBJECTIVE: Both bronchoscopic lung volume reduction with endobronchial valves (BLVR-EBV) and pulmonary rehabilitation (PR) are effective treatments for improving exercise capacity and patient-reported outcomes in patients with severe Chronic Obstructive Pulmonary Disease (COPD). According to current recommendations, all BLVR-EBV patients should have undergone PR first. Our aim was to study the effects of PR both before and after BLVR-EBV compared to BLVR-EBV alone. METHODS: We included patients with severe COPD who were eligible for BLVR-EBV and PR. Participants were randomized into three groups: PR before BLVR-EBV, PR after BLVR-EBV or BLVR-EBV without PR. The primary outcome was change in constant work rate cycle test (CWRT) endurance time at 6-month follow-up of the PR groups compared to BLVR-EBV alone. Secondary endpoints included changes in 6-minute walking test, daily step count, dyspnoea and health-related quality of life. RESULTS: Ninety-seven participants were included. At 6-month follow-up, there was no difference in change in CWRT endurance time between the PR before BLVR-EBV and BLVR-EBV alone groups (median: 421 [IQR: 44; 1304] vs. 787 [123; 1024] seconds, p = 0.82) or in any of the secondary endpoints, but the PR after BLVR-EBV group exhibited a smaller improvement in CWRT endurance time (median: 107 [IQR: 2; 573], p = 0.04) and health-related quality of life compared to BLVR-EBV alone. CONCLUSION: The addition of PR to BLVR-EBV did not result in increased exercise capacity, daily step count or improved patient-reported outcomes compared to BLVR-EBV alone, neither when PR was administered before BLVR-EBV nor when PR was administered after BLVR-EBV.
Asunto(s)
Broncoscopía , Tolerancia al Ejercicio , Neumonectomía , Enfisema Pulmonar , Calidad de Vida , Humanos , Masculino , Femenino , Broncoscopía/métodos , Neumonectomía/métodos , Anciano , Enfisema Pulmonar/cirugía , Enfisema Pulmonar/rehabilitación , Enfisema Pulmonar/fisiopatología , Persona de Mediana Edad , Resultado del Tratamiento , Prueba de Paso , Enfermedad Pulmonar Obstructiva Crónica/rehabilitación , Enfermedad Pulmonar Obstructiva Crónica/cirugía , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Prótesis e Implantes , Factores de Tiempo , Índice de Severidad de la EnfermedadRESUMEN
Excessive dynamic airway collapse (EDAC) contributes to breathlessness and reduced quality of life in individuals with emphysema. We tested a novel, portable, oral positive expiratory pressure (o-PEP) device in a patient with emphysema and EDAC. MRI revealed expiratory tracheal narrowing to 80 mm2 that increased to 170 mm2 with the o-PEP device. After 2-weeks use of the o-PEP device for 33% to 66% of activities, breathlessness, quality of life, and exertional dyspnea improved compared with minimal clinically important differences (MCID): University of California-San Diego Shortness of Breath questionnaire score declined 69 to 42 (MCID, ≥5), St. George's Respiratory Questionnaire score decreased 71 to 27 (MCID, ≥4), and before and after the 6-minute walk test Borg score difference improved from Δ3 to Δ2 (MCID, ≥1). During the 6-minute walk test on room air without the use of the o-PEP device, oxyhemoglobin saturation declined 91% to 83%; whereas, with the o-PEP device, the nadir was 90%. Use of the o-PEP device reduced expiratory central airway collapse and improved dyspnea, quality of life, and exertional desaturation in a patient with EDAC and emphysema.
Asunto(s)
Bronquiectasia/rehabilitación , Disnea/rehabilitación , Equipos y Suministros , Enfermedades por Almacenamiento Lisosomal/rehabilitación , Presión , Enfisema Pulmonar/rehabilitación , Mecánica Respiratoria , Adulto , Bronquiectasia/fisiopatología , Broncoscopía , Presión de las Vías Aéreas Positiva Contínua , Disnea/fisiopatología , Diseño de Equipo , Femenino , Humanos , Enfermedades por Almacenamiento Lisosomal/fisiopatología , Imagen por Resonancia Magnética , Oximetría , Oxihemoglobinas , Impresión Tridimensional , Enfisema Pulmonar/fisiopatología , Calidad de Vida , Tráquea/fisiopatología , Prueba de PasoRESUMEN
BACKGROUND: Lung volume reduction surgery (LVRS) performed to treat patients with severe diffuse emphysema was reintroduced in the nineties. Lung volume reduction surgery aims to resect damaged emphysematous lung tissue, thereby increasing elastic properties of the lung. This treatment is hypothesised to improve long-term daily functioning and quality of life, although it may be costly and may be associated with risks of morbidity and mortality. Ten years have passed since the last version of this review was prepared, prompting us to perform an update. OBJECTIVES: The objective of this review was to gather all available evidence from randomised controlled trials comparing the effectiveness of lung volume reduction surgery (LVRS) versus non-surgical standard therapy in improving health outcomes for patients with severe diffuse emphysema. Secondary objectives included determining which subgroup of patients benefit from LVRS and for which patients LVRS is contraindicated, to establish the postoperative complications of LVRS and its morbidity and mortality, to determine which surgical approaches for LVRS are most effective and to calculate the cost-effectiveness of LVRS. SEARCH METHODS: We identified RCTs by using the Cochrane Airways Group Chronic Obstructive Pulmonary Disease (COPD) register, in addition to the online clinical trials registers. Searches are current to April 2016. SELECTION CRITERIA: We included RCTs that studied the safety and efficacy of LVRS in participants with diffuse emphysema. We excluded studies that investigated giant or bullous emphysema. DATA COLLECTION AND ANALYSIS: Two independent review authors assessed trials for inclusion and extracted data. When possible, we combined data from more than one study in a meta-analysis using RevMan 5 software. MAIN RESULTS: We identified two new studies (89 participants) in this updated review. A total of 11 studies (1760 participants) met the entry criteria of the review, one of which accounted for 68% of recruited participants. The quality of evidence ranged from low to moderate owing to an unclear risk of bias across many studies, lack of blinding and low participant numbers for some outcomes. Eight of the studies compared LVRS versus standard medical care, one compared two closure techniques (stapling vs laser ablation), one looked at the effect of buttressing the staple line on the effectiveness of LVRS and one compared traditional 'resectional' LVRS with a non-resectional surgical approach. Participants completed a mandatory course of pulmonary rehabilitation/physical training before the procedure commenced. Short-term mortality was higher for LVRS (odds ratio (OR) 6.16, 95% confidence interval (CI) 3.22 to 11.79; 1489 participants; five studies; moderate-quality evidence) than for control, but long-term mortality favoured LVRS (OR 0.76, 95% CI 0.61 to 0.95; 1280 participants; two studies; moderate-quality evidence). Participants identified post hoc as being at high risk of death from surgery were those with particularly impaired lung function, poor diffusing capacity and/or homogenous emphysema. Participants with upper lobe-predominant emphysema and low baseline exercise capacity showed the most favourable outcomes related to mortality, as investigators reported no significant differences in early mortality between participants treated with LVRS and those in the control group (OR 0.87, 95% CI 0.23 to 3.29; 290 participants; one study), as well as significantly lower mortality at the end of follow-up for LVRS compared with control (OR 0.45, 95% CI 0.26 to 0.78; 290 participants; one study). Trials in this review furthermore provided evidence of low to moderate quality showing that improvements in lung function parameters other than forced expiratory volume in one second (FEV1), quality of life and exercise capacity were more likely with LVRS than with usual follow-up. Adverse events were more common with LVRS than with control, specifically the occurrence of (persistent) air leaks, pulmonary morbidity (e.g. pneumonia) and cardiovascular morbidity. Although LVRS leads to an increase in quality-adjusted life-years (QALYs), the procedure is relatively costly overall. AUTHORS' CONCLUSIONS: Lung volume reduction surgery, an effective treatment for selected patients with severe emphysema, may lead to better health status and lung function outcomes, specifically for patients who have upper lobe-predominant emphysema with low exercise capacity, but the procedure is associated with risks of early mortality and adverse events.
Asunto(s)
Pulmón/cirugía , Neumonectomía/métodos , Enfisema Pulmonar/cirugía , Adulto , Humanos , Terapia por Láser , Neumonectomía/mortalidad , Enfisema Pulmonar/mortalidad , Enfisema Pulmonar/rehabilitación , Ensayos Clínicos Controlados Aleatorios como Asunto , Grapado Quirúrgico , SuturasRESUMEN
INTRODUCTION: Combined pulmonary fibrosis and emphysema has recently been recognized as a syndrome but remains under-diagnosed. Neither clinical management nor therapeutic approaches have been clearly defined. Pulmonary rehabilitation has not been considered within the therapeutic options for combined pulmonary fibrosis and emphysema. In this case we explored the potential benefits of a specific aerobic physical retraining program in the management of combined pulmonary fibrosis and emphysema. CASE PRESENTATION: We describe the case of a 65-year-old Caucasian man with combined pulmonary fibrosis and emphysema and respiratory failure who was receiving long-term oxygen therapy. Our patient underwent physical retraining with moderate intensity aerobic and breathing exercises for four weeks. Clinical and motor tests, as well as questionnaires assessing quality of life and depression levels, were performed prior to and following the retraining. At the end of the retraining program a relevant reduction of long-term oxygen therapy requirement was registered; improvements in terms of physical performance, quality of life, and mood were observed in our patient but no change in respiratory parameters. CONCLUSIONS: A program of aerobic physical retraining appears to be beneficial to patients with combined pulmonary fibrosis and emphysema and may be considered as an additional therapeutic option.
Asunto(s)
Terapia por Ejercicio , Enfisema Pulmonar/rehabilitación , Fibrosis Pulmonar/rehabilitación , Anciano , Ejercicios Respiratorios/métodos , Ejercicio Físico/fisiología , Humanos , Masculino , Terapia por Inhalación de Oxígeno/métodos , Enfisema Pulmonar/etiología , Fibrosis Pulmonar/etiología , Síndrome , Nicotiana/efectos adversosRESUMEN
CONTEXTO: O enfisema, que se encaixa dentro do espectro de Doenças Pulmonares Obstrutivas Crônicas (DPOC), é caracterizado pela destruição do tecido alveolar e pela fragilidade estrutural provocada por elastólise e obstrução de vias aéreas, por sua vez provocada por perda de sustentação ou por alterações inflamatórias nas paredes das vias aéreas. A limitação de fluxo aéreo é progressiva e está associada a uma resposta inflamatória anormal do pulmão a partículas ou gases nocivos, dentre os quais 75% são provenientes do tabagismo. A lesão nos tecidos pulmonares causa uma diminuição de elasticidade, hiperinsuflação progressiva e aprisionamento de ar, sendo essas as consequências mais devastadoras do enfisema. Em consequência disso, ocorre comprometimento da capacidade de exercício por conta do aumento do tamanho do pulmão, que atinge um volume que impede sua expansão e funcionamento adequados na caixa torácica, e perda de qualidade de vida. Do ponto de vista terapêutico, os medicamentos broncodilatadores apresentam resposta limitada nessa doença e, tendo em vista que o maior objetivo do tratamento do enfisema é reduzir o ar aprisionado, várias abordagens terapêuticas invasivas ganharam destaque na investigação científica. No âmbito do Sistema Único de Saúde (SUS), existem três formas de tratamento para pacientes com enfisema pulmonar: tratamento clínico, tratamento cirúrgico e o transplante pulmonar. A Cirurgia Redutora do Volume Pulmonar (CRVP) é o procedimento de escolha a ser comparado ao método proposto pelo demandante, ou seja, o implante broncoscópico de válvulas endobronquiais unidirecionais. TRATAMENTO RECOMENDADO: Os objetivos terapêuticos em pacientes com DPOC são direcionados a aliviar parte da obstrução das vias aéreas que é reversível; controlar a tosse e a produção de secreções; eliminar e evitar as infecções das vias aéreas; aumentar a tolerância ao exercício ao máximo permitido pelo nível individual de déficit fisiológico; controlar as complicações médicas, como hipoxemia arterial e problema cardiovasculares; evitar o fumo e outros irritantes das vias aéreas e aliviar a ansiedade e a depressão. As modalidades de tratamento para DPOC consistem em terapia com broncodilatadores, corticóides inalatórios, antibióticos, oxigenoterapia, ventilação mecânica e intervenção cirúrgica. A cessação do tabagismo é o mais simples e efetivo modo para redução do risco de DPOC e interrupção de sua progressão. Quando o tratamento medicamentoso máximo não é suficiente para compensar o quadro de doença brônquica a que costuma estar associado, a alternativa médica que resta é o treinamento físico para melhorar a eficiência dos músculos respiratórios e acessórios, reduzir o consumo de oxigênio e aumentar a tolerância à dispneia (conhecida como reabilitação respiratória). Enquanto os pacientes com predominância do componente de bronquite crônica são passíveis de um maior número de opções terapêuticas, aqueles com predomínio de enfisema têm, na reabilitação respiratória e nos cuidados nutricionais, os maiores recursos de manejo clínico. Há muito se busca alternativas para o tratamento de pacientes com enfisema, em função dessas limitações ao tratamento clínico. A TECNOLOGIA: A tecnologia aqui proposta para o tratamento do enfisema grave, forma heterogênea, possui registro n° 8015901001 na Agência Nacional de Vigilância Sanitária (ANVISA) desde 2008. Consiste no implante permanente, via broncoscópica, de válvulas unidirecionais. Essas válvulas são projetadas para controlar o fluxo de ar a fim de melhorar a função pulmonar em pacientes com enfisema heterogêneo e/ou reduzir escapes de ar. O uso das válvulas endobronquiais, usualmente, retira os pacientes com grave disfunção pulmonar do suporte respiratório (entubação endotraqueal/ assistência ventilatória), melhorando de forma muito significativa sua qualidade de vida. Esses são os doentes que não apresentam condições cirúrgicas para o transplante pulmonar. Por outro lado, permite condições de espera para aqueles doentes que aguardam o transplante pulmonar, obviamente, quando indicado. CONSIDERAÇÕES FINAIS: A evidência atualmente disponível sobre eficácia, efetividade e segurança da válvula endobronquial para tratamento do enfisema pulmonar heterogêneo foi baseada em oito estudos observacionais (série de casos) e dois ensaios clínicos randomizados, com nível de evidência baixo ou muito baixo e grau de recomendação fraco em favor da tecnologia (GRADE). Nesse sentido, os resultados apresentados pelos estudos indicam que o implante de válvulas endobronquiais é seguro em curto prazo, apresenta melhora de discreta a moderada na função pulmonar e na qualidade de vida. No entanto, essas evidências incluem dados de pacientes que tiveram e daqueles que não tiveram avaliação de ventilação colateral, fato que especialistas aconselham como fundamental para a seleção do tratamento atualmente. As evidências de segurança em curto prazo são adequadas, mas evidências de segurança em longo prazo ainda são insuficientes. DELIBERAÇÃO FINAL: Os membros da CONITEC, presentes na 26ª reunião da CONITEC, realizada no dia 09/06/2014, deliberaram, por unanimidade, por não recomendar a incorporação da válvula endobronquial ZEPHYR unidirecional para o tratamento do enfisema pulmonar heterogêneo associado à ventilação colateral reduzida. DECISÃO: PORTARIA Nº 33, de 26 de setembro de 2014 - Torna pública a decisão de não incorporar o implante de válvulas endobronquiais unidirecionais para o tratamento do enfisema pulmonar heterogêneo no âmbito do Sistema Único de Saúde SUS.
Asunto(s)
Humanos , Enfisema Pulmonar/rehabilitación , Válvula Pulmonar , Ventilación Pulmonar , Implantación de Prótesis , Sistema Único de Salud , Brasil , Análisis Costo-BeneficioRESUMEN
OBJECTIVE: To investigate the impact of a pulmonary rehabilitation program on the functional capacity and on the quality of life of patients on waiting lists for lung transplantation. METHODS: Patients on lung transplant waiting lists were referred to a pulmonary rehabilitation program consisting of 36 sessions. Before and after the program, participating patients were evaluated with the six-minute walk test and the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36). The pulmonary rehabilitation program involved muscle strengthening exercises, aerobic training, clinical evaluation, psychiatric evaluation, nutritional counseling, social assistance, and educational lectures. RESULTS: Of the 112 patients initially referred to the program, 58 completed it. The mean age of the participants was 46 ± 14 years, and females accounted for 52%. Of those 58 patients, 37 (47%) had pulmonary fibrosis, 13 (22%) had pulmonary emphysema, and 18 (31%) had other types of advanced lung disease. The six-minute walk distance was significantly greater after the program than before (439 ± 114 m vs. 367 ± 136 m, p = 0.001), the mean increase being 72 m. There were significant point increases in the scores on the following SF-36 domains: physical functioning, up 22 (p = 0.001), role-physical, up 10 (p = 0.045); vitality, up 10 (p < 0.001); social functioning, up 15 (p = 0.001); and mental health, up 8 (p = 0.001). CONCLUSIONS: Pulmonary rehabilitation had a positive impact on exercise capacity and quality of life in patients on lung transplant waiting lists.
Asunto(s)
Enfermedades Pulmonares/rehabilitación , Trasplante de Pulmón , Calidad de Vida , Listas de Espera , Adulto , Ejercicios Respiratorios , Terapia por Ejercicio/métodos , Tolerancia al Ejercicio , Femenino , Humanos , Fibrosis Pulmonar Idiopática/fisiopatología , Fibrosis Pulmonar Idiopática/rehabilitación , Enfermedades Pulmonares/fisiopatología , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Enfisema Pulmonar/fisiopatología , Enfisema Pulmonar/rehabilitación , Pruebas de Función Respiratoria , Estadísticas no ParamétricasRESUMEN
OBJECTIVE: To investigate the impact of a pulmonary rehabilitation program on the functional capacity and on the quality of life of patients on waiting lists for lung transplantation. METHODS: Patients on lung transplant waiting lists were referred to a pulmonary rehabilitation program consisting of 36 sessions. Before and after the program, participating patients were evaluated with the six-minute walk test and the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36). The pulmonary rehabilitation program involved muscle strengthening exercises, aerobic training, clinical evaluation, psychiatric evaluation, nutritional counseling, social assistance, and educational lectures. RESULTS: Of the 112 patients initially referred to the program, 58 completed it. The mean age of the participants was 46 ± 14 years, and females accounted for 52%. Of those 58 patients, 37 (47%) had pulmonary fibrosis, 13 (22%) had pulmonary emphysema, and 18 (31%) had other types of advanced lung disease. The six-minute walk distance was significantly greater after the program than before (439 ± 114 m vs. 367 ± 136 m, p = 0.001), the mean increase being 72 m. There were significant point increases in the scores on the following SF-36 domains: physical functioning, up 22 (p = 0.001), role-physical, up 10 (p = 0.045); vitality, up 10 (p < 0.001); social functioning, up 15 (p = 0.001); and mental health, up 8 (p = 0.001). CONCLUSIONS: Pulmonary rehabilitation had a positive impact on exercise capacity and quality of life in patients on lung transplant waiting lists. .
OBJETIVO: Avaliar o impacto de um programa de reabilitação pulmonar na capacidade funcional e na qualidade de vida de pacientes em lista de espera para transplante pulmonar. MÉTODOS: Pacientes em lista de espera para transplante pulmonar encaminhados a um programa de reabilitação pulmonar de 36 sessões. Os participantes foram avaliados no início e no final desse com o teste de caminhada de seis minutos (TC6) e com o questionário de qualidade de vida Medical Outcomes Study 36-item Short-Form Health Survey (SF-36). O programa de reabilitação pulmonar foi composto por exercícios de fortalecimento muscular, treinamento aeróbico, acompanhamento clínico e psiquiátrico, acompanhamento nutricional, assistência social e palestras educacionais. RESULTADOS: Dos 112 pacientes encaminhados, 58 completaram o programa. A média de idade dos participantes foi de 46 ± 14 anos; sendo 52% do sexo feminino. Entre esses pacientes, 37 (47%) eram portadores de fibrose pulmonar, 13 (22%) tinham enfisema pulmonar, e 18 (31%), tinham outras doenças pulmonares em fase avançada. Houve uma melhora significativa na distância percorrida no TC6 ao final do programa (367 ± 136 m vs. 439 ± 114 m; p = 0,001), com um aumento médio de 72 m. Houve aumentos significativos nas pontuações dos seguintes domínios do SF-36: capacidade funcional, 22 pontos (p = 0,001); aspectos físicos, 10 (p = 0,045); vitalidade, 10 (p < 0,001); aspectos sociais, 15 (p = 0,001); e saúde mental, 8 (p = 0,001). CONCLUSÕES: O programa de reabilitação pulmonar teve um impacto positivo na capacidade de exercício e na qualidade de vida nos pacientes em lista de espera para transplante pulmonar. .
Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Trasplante de Pulmón , Enfermedades Pulmonares/rehabilitación , Calidad de Vida , Listas de Espera , Ejercicios Respiratorios , Tolerancia al Ejercicio , Terapia por Ejercicio/métodos , Fibrosis Pulmonar Idiopática/fisiopatología , Fibrosis Pulmonar Idiopática/rehabilitación , Enfermedades Pulmonares/fisiopatología , Estudios Prospectivos , Enfisema Pulmonar/fisiopatología , Enfisema Pulmonar/rehabilitación , Pruebas de Función Respiratoria , Estadísticas no ParamétricasRESUMEN
BACKGROUND: Despite its benefit, lung volume reduction surgery (LVRS) is underused, partially because of the heterogeneous responses and lack of recent outcomes data. METHODS: Data from 59 consecutive emphysema patients who underwent LVRS were analyzed. The proportion of patients responding based on 6-minute walk distance (6-MWD), exercise capacity (watts), and forced expiratory volume in 1 second (FEV1) were calculated. Baseline variables were correlated with improvements in 6-MWD, maximal watts, and FEV1. RESULTS: Eighty-eight percent of patients responded to LVRS, with a higher proportion of FEV1 and 6-MWD responders in our cohort compared with similar patients from the National Emphysema Treatment Trial. Significant associations existed between lower baseline 6-MWD and increased 6-MWD after operation (r = -0.423), more extensive emphysema and increased FEV1 (r = 0.491), and hyperinflation and increased maximal watts (r = 0.438). The probability of survival was 0.93 at 90 days, 0.90 at 1 year, and 0.80 (3 years). The lowest exercise group (<20 watts on baseline testing) had an increased risk for death (RR 13.3, p = 0.001). CONCLUSIONS: There were durable improvements in FEV1 and exercise capacity in patients meeting the National Emphysema Treatment Trial criteria. Survival was comparable to that in similar patients from the National Emphysema Treatment Trial; response rates were higher in our cohort for FEV1 and 6-MWD. Those with lower 6-MWD, more emphysema, and more hyperinflation at baseline were most likely to respond to LVRS. Those with lowest exercise capacity at baseline may have a higher risk of death after LVRS.
Asunto(s)
Selección de Paciente , Neumonectomía/métodos , Enfisema Pulmonar/cirugía , Calidad de Vida , Capacidad Pulmonar Total/fisiología , Anciano , Medicina Basada en la Evidencia , Tolerancia al Ejercicio , Femenino , Estudios de Seguimiento , Volumen Espiratorio Forzado/fisiología , Humanos , Masculino , Persona de Mediana Edad , Neumonectomía/mortalidad , Cuidados Posoperatorios/métodos , Enfisema Pulmonar/diagnóstico , Enfisema Pulmonar/rehabilitación , Pruebas de Función Respiratoria , Medición de Riesgo , Índice de Severidad de la Enfermedad , Tasa de Supervivencia , Resultado del TratamientoRESUMEN
Although pulmonary rehabilitation is recommended for patients undergoing lung volume reduction surgery, the optimal method of pulmonary rehabilitation is unclear. The aim of this study was to determine the feasibility and safety of perioperative short-term pulmonary rehabilitation. We enrolled candidates for lung volume reduction surgery from 1999 to 2006 and retrospectively evaluated the feasibility and safety of perioperative short-term pulmonary rehabilitation for these patients. The program included the progressive exercise training on a treadmill for approximately 3 weeks. Two primary endpoints, feasibility and safety, were determined by the adherence rates of the program session and the adverse events. Pulmonary function and exercise capacity were evaluated at baseline and the termination of pre- and postoperative short-term pulmonary rehabilitation. Twenty-two patients were enrolled in this study. All patients completed our program without any serious adverse events. The mean values of adherence rates of the preoperative, postoperative, and overall period were, 89.1%, 95.1%, and 92.1%, respectively. All values of pulmonary function tests, except for forced vital capacity, significantly improved at the termination of postoperative short-term pulmonary rehabilitation in comparison to those at the termination of preoperative short-term pulmonary rehabilitation. The values of the 6-minute walk distance, total exercise time, and maximal workload on incremental exercise test were significantly improved by preoperative short-term pulmonary rehabilitation, and their values were maintained until the termination of postoperative short-term pulmonary rehabilitation. The results indicated that it is both feasible and safe to perform perioperative short-term pulmonary rehabilitation.
Asunto(s)
Atención Perioperativa , Neumonectomía , Enfisema Pulmonar/rehabilitación , Enfisema Pulmonar/cirugía , Terapia Respiratoria , Anciano , Ejercicio Físico , Prueba de Esfuerzo , Estudios de Factibilidad , Femenino , Humanos , Masculino , Entrenamiento de Fuerza , Pruebas de Función Respiratoria , Estudios RetrospectivosRESUMEN
PURPOSE: Pulmonary rehabilitation (PR) programs have been shown to improve functional status, exercise performance, and quality of life (QOL) and decrease perception of exertion in individuals with chronic obstructive pulmonary disease. The purpose of this study was to identify the dose effect of PR on the outcome variables of activity level, perceived exertion, and physical and mental QOL. METHODS: The study used a retrospective explanatory design. The sample (N = 104) included records of individuals diagnosed with chronic bronchitis and emphysema who attended a PR program from 2000 to 2005 at a Midwest inner-city, academic medical center. Participants attended rehabilitation sessions 2 to 3 days per week for approximately 90 minutes each day; maximum duration of the program was 3 months (24 sessions). The PR dose was calculated by multiplying the number of PR sessions with the number of weeks attended. RESULTS: There were 32 men and 72 women, with a mean age of 59.9 years +/- 10.2 years. All patients were retired or unemployed, and 99% used oxygen during exercise. A higher PR dose was significantly related to improvement in activity level measured by maximum metabolic equivalent (MET) level achieved. A nonsignificant but minimally clinically important difference was found on the Medical Outcomes Study Short-Form 36 (SF-36) outcomes of mental and physical QOL. CONCLUSIONS: The findings of the current study support a significant relationship between PR dose and activity level (maximum MET level achieved). Physical and mental QOL improved clinically after PR. Optimal program outcomes were related to greater patient participation in supervised PR.
Asunto(s)
Bronquitis Crónica/rehabilitación , Terapia por Ejercicio/métodos , Tolerancia al Ejercicio/fisiología , Educación del Paciente como Asunto/métodos , Esfuerzo Físico/fisiología , Enfisema Pulmonar/rehabilitación , Adulto , Anciano , Anciano de 80 o más Años , Bronquitis Crónica/fisiopatología , Femenino , Estudios de Seguimiento , Volumen Espiratorio Forzado/fisiología , Humanos , Masculino , Persona de Mediana Edad , Enfisema Pulmonar/fisiopatología , Calidad de Vida , Estudios Retrospectivos , Factores de Tiempo , Resultado del TratamientoRESUMEN
Potential candidates for lung volume reduction surgery should undergo extensive evaluation and preparation to minimize perioperative risks and optimize surgical outcomes. Initial screening includes spirometry, diffusion capacity, lung volumes by body plethysmography, and high-resolution computerized tomography scanning. Patients who have been successfully screened must complete a preoperative pulmonary rehabilitation program of 6-10 weeks duration. During the pulmonary rehabilitation program, medical therapy should be maximized. Postrehabilitation studies include cardiopulmonary exercise testing, arterial blood gas analysis, oxygen titration, six-minute walk, and cardiac testing. The evaluation process aims at defining the severity and distribution of emphysema and attempts to eliminate those who do not meet criteria outlined by the National Emphysema Treatment Trial. Optimal candidates have upper-lobe-predominant emphysema and acceptable operative risks.
Asunto(s)
Selección de Paciente , Neumonectomía , Enfisema Pulmonar/cirugía , Análisis de los Gases de la Sangre , Prueba de Esfuerzo , Humanos , Complicaciones Posoperatorias/prevención & control , Cuidados Preoperatorios , Enfisema Pulmonar/fisiopatología , Enfisema Pulmonar/rehabilitación , Ensayos Clínicos Controlados Aleatorios como Asunto , Pruebas de Función Respiratoria , Factores de Riesgo , Tomografía Computarizada por Rayos XRESUMEN
Pulmonary rehabilitation is an established treatment for patients with chronic lung disease. Benefits include improvement in exercise tolerance, symptoms, and quality of life, with a reduction in the use of health care resources. As an adjunct to surgical programs, such as lung volume reduction surgery, pulmonary rehabilitation plays an important role not just in preparing patients for surgery and facilitating recovery but also in selecting patients and ensuring informed choices about treatment options after optimal medical care. In the National Emphysema Treatment Trial (NETT), subjects completed 6-10 weeks of comprehensive pulmonary rehabilitation before randomization and continued rehabilitation throughout the trial, both at home and with intermittent supervision at either an NETT center or an NETT-certified satellite center. Sessions included a combination of upper and lower extremity exercise, education, and psychosocial support. Before randomization, pulmonary rehabilitation resulted in highly significant changes in exercise capacity, dyspnea, and quality of life. As expected, improvements were significantly greater in those without prior rehabilitation experience. Results for patients completing rehabilitation at satellites were similar to those at NETT centers. Prerandomization pulmonary rehabilitation had a significant effect on outcome after lung volume reduction surgery. NETT identified subgroups with differential outcome by treatment (surgical vs. nonsurgical), defined in part by postrehabilitation maximum exercise capacity. Overall, NETT demonstrated the effectiveness of pulmonary rehabilitation in improving function, symptoms, and health status in a large cohort of patients with advanced emphysema treated in a cross-section of programs in the United States.
Asunto(s)
Enfisema Pulmonar/rehabilitación , Disnea/rehabilitación , Terapia por Ejercicio , Tolerancia al Ejercicio , Humanos , Estudios Multicéntricos como Asunto , Educación del Paciente como Asunto , Neumonectomía , Enfisema Pulmonar/cirugía , Calidad de Vida , Ensayos Clínicos Controlados Aleatorios como Asunto , Pruebas de Función Respiratoria , Apoyo Social , Resultado del Tratamiento , Estados UnidosRESUMEN
This study reports the costs associated with rehabilitation among participants in the National Emphysema Treatment Trial (NETT), and evaluates factors associated with adherence to rehabilitation. Pulmonary rehabilitation is recommended for moderate-to-severe COPD and required by the Centers for Medicare and Medicaid Services (CMS) prior to lung volume reduction surgery (LVRS). Between January 1998 and July 2002, 1,218 subjects with emphysema and severe airflow limitation (FEV(1) < or = 45% predicted) were randomized. Primary outcome measures were designated as mortality and maximal exercise capacity 2 years after randomization. Pre-randomization, estimated mean total cost per patient of rehabilitation was $2,218 (SD $314; 2006 dollars) for the medical group and $2,187 (SD $304) for the surgical group. Post-randomization, mean cost per patient in the medical and surgical groups was $766 and $962 respectively. Among patients who attended > or = 1 post-randomization rehabilitation session, LVRS patients, patients with an FEV(1) > or = 20% predicted, and higher education were significantly more likely to complete rehabilitation. Patients with depressive and anxiety symptoms, and those who live > 36 miles compared to < 6 miles away were less likely to be adherent. Patients who underwent LVRS completed more exercise sessions than those in the medical group and were more likely to be adherent with post-randomization rehabilitation. A better understanding of patient factors such as socioeconomic status, depression, anxiety and transportation issues may improve adherence to pulmonary rehabilitation.
Asunto(s)
Cooperación del Paciente , Enfisema Pulmonar/economía , Enfisema Pulmonar/rehabilitación , Anciano , Consejo/economía , Terapia por Ejercicio/economía , Femenino , Volumen Espiratorio Forzado , Humanos , Masculino , Educación del Paciente como Asunto/economía , Enfisema Pulmonar/fisiopatología , Enfisema Pulmonar/cirugíaRESUMEN
BACKGROUND: Oxygen consumption volume (VO2) and resting energy expenditure are increased in emphysema because of impaired respiratory function and mechanics, with greater oxygen cost of breathing and altered metabolism. We hypothesized that lung volume reduction surgery may improve energy expenditure and metabolism. METHODS: In this 1-year prospective study, 30 patients with moderate-to-severe emphysema underwent bilateral lung volume reduction surgery; 28 similar patients, who refused operation, followed a standard respiratory rehabilitation program. Oxygen consumption volume and resting energy expenditure, both corrected for fat-free mass, VO2 proportion of respiratory muscles (%VO2Resp), respiratory quotient, and energy substrate oxidation were determined by using a calorimetric chamber with indirect methods. RESULTS: Only after surgery significant improvements resulted in 1-second forced expiratory volume (+20.4%, p = 0.009), residual volume (-24.8%, p = 0.001), diffusion-lung carbon-monoxide (+18.4%, p = 0.008), body mass index (+5.5%, p = 0.01), resting energy expenditure (-8.2%, p = 0.006), and %VO2Resp (-44.1%, p = 0.0008) with increase in respiratory quotient (0.79 versus 0.84, p = 0.03) and conversion from prevalent lipid (44.6% versus 34.3%, p = 0.0007) to prevalent carbohydrate (25.2% versus 42.2%, p = 0.0006) metabolism. Thirteen operated on patients discontinued oral steroids, showing the most significant improvements. The remaining 17 experienced significant changes compared with the rehabilitation group despite oral steroids (resting energy expenditure -7.0% versus +4.1%, and %VO2Resp -34.0% versus +0.7%, p = 0.001). Decrease of resting energy expenditure and %VO2Resp correlated with reduction of residual volume (p = 0.02 and p = 0.001) and increment of body mass index (p = 0.03 and p = 0.004). CONCLUSIONS: Lung volume reduction surgery significantly decreased %VO2Resp and resting energy expenditure over respiratory rehabilitation and despite oral steroid therapy. Substrate oxidation changed from prevalent lipid to prevalent carbohydrate. Correlations with residual volume and nutritional status suggest that restoration of respiratory mechanics reduces energy expenditure and approximates metabolism to normal.
Asunto(s)
Metabolismo Energético/fisiología , Consumo de Oxígeno/fisiología , Neumonectomía , Enfisema Pulmonar/rehabilitación , Enfisema Pulmonar/cirugía , Anciano , Glucocorticoides/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Evaluación Nutricional , Estudios Prospectivos , Enfisema Pulmonar/metabolismo , Enfisema Pulmonar/terapia , Pruebas de Función Respiratoria , Descanso/fisiologíaRESUMEN
BACKGROUND: We present a summary report evaluating the efficacy of lung volume reduction surgery (LVRS) in patients with advanced emphysema in the Canadian setting. METHODS: Quality of Life measures assessed the efficacy of adding LVRS to best medical care including rehabilitation in this blinded randomized multicentered controlled trial with 2 years of follow-up. Health utility and quality-adjusted life years (QALY) were outcomes central to our economic assessment. RESULTS: None of the 32 patients randomized to the LVRS arm or 30 patients in the best medical care (BMC) arm crossed-over and no patients were lost to follow-up. Overall surgical mortality was 16% at 2 years while the overall medical mortality was 13% (p = 0.914). There were no 30-day postoperative deaths but 2 deaths (6%) occurred within 90 days of randomization. Surgery reduced the residual volume measured at 6 months by 23% (5,385 mL to 4,322 mL, p = 0.007). There was an increase in forced expiratory volume in 1 second (FEV1) of 30% (265 mL, p = 0.013) from baseline, an improvement in the six minute walk test (6MWT) of 78 meters (p = 0.045), and an increase in Health Utility Index 3 (HUI3) which peaked at 6 months with a difference of 0.16 (p = 0.129). There was a gain in QALYs of 0.21 (p = 0.19) in the LVRS-arm over the BMC-arm. The LVRS costs an additional 28,119 Canadian dollars (CAD) compared with BMC or 133,900 CAD/QALY gained. CONCLUSIONS: The addition of LVRS to best medical care including pulmonary rehabilitation improves pulmonary function, exercise activity, and quality of life in selected patients with advanced emphysema. Cost is high but in keeping with other treatment modalities currently available.
Asunto(s)
Neumonectomía , Enfisema Pulmonar/cirugía , Anciano , Canadá , Análisis Costo-Beneficio , Costos y Análisis de Costo , Femenino , Volumen Espiratorio Forzado , Costos de Hospital , Humanos , Masculino , Persona de Mediana Edad , Terapia por Inhalación de Oxígeno/economía , Neumonectomía/economía , Neumonectomía/estadística & datos numéricos , Complicaciones Posoperatorias/epidemiología , Enfisema Pulmonar/economía , Enfisema Pulmonar/rehabilitación , Enfisema Pulmonar/terapia , Años de Vida Ajustados por Calidad de Vida , Encuestas y Cuestionarios , Resultado del TratamientoAsunto(s)
Educación del Paciente como Asunto/métodos , Enfisema Pulmonar/rehabilitación , Enfisema Pulmonar/cirugía , Anciano , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Estudios Multicéntricos como Asunto , Selección de Paciente , Neumonectomía/métodos , Cuidados Preoperatorios/métodos , Estudios Prospectivos , Enfisema Pulmonar/diagnóstico , Ensayos Clínicos Controlados Aleatorios como Asunto , Índice de Severidad de la Enfermedad , Resultado del TratamientoRESUMEN
STUDY OBJECTIVES: Pulmonary rehabilitation is an established treatment in patients with chronic lung disease but is not widely utilized. Most trials have been conducted in single centers. The National Emphysema Treatment Trial (NETT) provided an opportunity to evaluate pulmonary rehabilitation in a large cohort of patients who were treated in centers throughout the United States. DESIGN: Prospective observational study of cohort prior to randomization in a multicenter clinical trial. SETTING: University-based clinical centers and community-based satellite pulmonary rehabilitation programs. PATIENTS AND INTERVENTION: A total of 1,218 patients with severe emphysema underwent pulmonary rehabilitation before and after randomization to lung volume reduction surgery (LVRS) or continued medical management. Rehabilitation was conducted at 17 NETT centers supplemented by 539 satellite centers. MEASUREMENTS AND RESULTS: Lung function, exercise tolerance, dyspnea, and quality of life were evaluated at regular intervals. Significant (p < 0.001) improvements were observed consistently in exercise (cycle ergometry, 3.1 W; 6-min walk test distance, 76 feet), dyspnea (University of California, San Diego Shortness of Breath Questionnaire score, -3.2; Borg breathlessness score: breathing cycle, -0.8; 6-min walk, -0.5) and quality of life (St. George Respiratory Questionnaire score, -3.5; Quality of Well-Being Scale score, +0.035; Medical Outcomes Study 36-item short form score: physical health summary, +1.3; mental health summary, + 2.0). Patients who had not undergone prior rehabilitation improved more than those who had. In multivariate models, only prior rehabilitation status predicted changes after rehabilitation. In 20% of patients, exercise level changed sufficiently after rehabilitation to alter the NETT subgroup predictive of outcome. Overall, changes after rehabilitation did not predict differential mortality or improvement in exercise (primary outcomes) by treatment group. CONCLUSIONS: The NETT experience demonstrates the effectiveness of pulmonary rehabilitation in patients with severe emphysema who were treated in a national cross-section of programs. Pulmonary rehabilitation plays an important role in preparing and selecting patients for surgical interventions such as LVRS.
Asunto(s)
Cuidados Preoperatorios/métodos , Enfisema Pulmonar/rehabilitación , Enfisema Pulmonar/cirugía , Anciano , Intervalos de Confianza , Femenino , Estudios de Seguimiento , Humanos , Modelos Lineales , Masculino , Persona de Mediana Edad , Análisis Multivariante , Modalidades de Fisioterapia , Neumonectomía/métodos , Probabilidad , Estudios Prospectivos , Enfisema Pulmonar/diagnóstico , Valores de Referencia , Pruebas de Función Respiratoria , Medición de Riesgo , Índice de Severidad de la Enfermedad , Resultado del TratamientoRESUMEN
BACKGROUND: In patients with severe emphysema, bone mineral density (BMD) is reduced and the risk of osteoporosis is increased. STUDY OBJECTIVES: To identify the impact of lung volume reduction surgery on BMD. DESIGN: Prospective cohort study. SETTING: University hospital. PATIENTS AND INTERVENTIONS: Forty emphysematous patients, all receiving oral steroid therapy, underwent bilateral lung volume reduction surgery. Thirty similar patients, who refused the operation, followed a standard respiratory rehabilitation program. MEASUREMENTS: All subjects were evaluated pretreatment and 12 months posttreatment for respiratory function, nutritional status, and bone-related biochemical parameters. BMD was assessed by dual-energy radiograph absorptiometry. RESULTS: After surgery, we observed significant improvements in respiratory function (FEV1, + 18.8% [p < 0.01]; residual volume [RV], -29.6% [p < 0.001]; diffusing capacity of the lung for carbon monoxide [Dlco], + 21.6% [p < 0.01]) nutritional parameters (fat-free mass, + 6.0% [p < 0.01]), levels of bone-related hormones (free-testosterone, + 20.5% [p < 0.01]; parathormone, -11.2% [p < 0.01]), bone turnover markers (osteocalcin, -12.7% [p < 0.05]; bone-alkaline-phosphatase, -14.0% [p < 0.05]; beta-crosslaps, -33.6% [p < 0.001]), BMD (lumbar, + 8.8% [p < 0.01]; femoral, + 5.5% [p < 0.01]), and T-score (lumbar, + 21.0% [p < 0.01]; femoral, + 12.4% [p < 0.01]) with reduction in osteoporosis rate (50 to 25%). Nineteen patients who had undergone surgery were able to discontinue treatment with oral steroids. These subjects showed a more significant improvement in BMD (lumbar, + 9.6%; femoral, + 6.8%; p < 0.001) and T-score (lumbar, + 27.3%; femoral, + 14.3%; p < 0.001). The remaining 21 patients who had undergone surgery experienced significant improvement compared to respiratory rehabilitation subjects despite continued therapy with oral steroids (BMD: lumbar, + 4.5% vs -0.7%, respectively [p < 0.01]; femoral, + 2.7% vs -1.1%, respectively [p < 0.05]; T-score: lumbar, + 14 vs -2.1, respectively [p < 0.01]; femoral, + 7.4 vs -2.7, respectively [p < 0.01]). The increase in lumbar BMD was correlated with the surgical reduction of RV (p = 0.02) and with the increase in Dlco (p = 0.01) and fat-free mass (p = 0.01). CONCLUSIONS: Lung volume reduction surgery significantly improves BMD compared to respiratory rehabilitation therapy, even in patients requiring oral steroids. The increase in BMD correlates with RV, Dlco, and fat-free mass, suggesting that the restoration of respiratory dynamics, gas exchange, and nutritional status induces improvement in bone metabolism and mineral content.
Asunto(s)
Densidad Ósea/fisiología , Neumonectomía/métodos , Enfisema Pulmonar/rehabilitación , Enfisema Pulmonar/cirugía , Terapia Respiratoria/métodos , Absorciometría de Fotón , Anciano , Índice de Masa Corporal , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Osteoporosis/prevención & control , Probabilidad , Estudios Prospectivos , Enfermedad Pulmonar Obstructiva Crónica/diagnóstico , Enfermedad Pulmonar Obstructiva Crónica/rehabilitación , Enfermedad Pulmonar Obstructiva Crónica/cirugía , Enfisema Pulmonar/diagnóstico , Pruebas de Función Respiratoria , Medición de Riesgo , Índice de Severidad de la Enfermedad , Resultado del TratamientoRESUMEN
Lung volume reduction surgery (LVRS) is an experimental surgical procedure that aims to alleviate the symptoms of breathlessness for patients with end-stage chronic emphysema. Emphysema (from the Greek for 'puff up') is a progressive chronic obstructive pulmonary disease (COPD) and risk factors include smoking and chronic infections. The disease causes the alveoli of the lung to over-expand and lose their elasticity (Schedel and Connolly, 1999). Advanced emphysema causes severe dyspnoea that significantly reduces the patient's quality of life.